3.3 Clinical trials A clinical trial was conducted to assess the protective properties of a unique botanical combination comprising lutein ester, zeaxanthin, and extracts from blackcurrant, chrysanthemum, and goji berry on people suffering from eye fatigue and dry eye syndrome
Newer dual GLP-1/GIP receptor agonists have been developed that can more easily cross the BBB and that show improved protection in animal models of AD and PD
PAG1, Phosphoprotein Associated With Glycosphingolipid Microdomains 1
Although antioxidant-based therapies are biologically compelling, their clinical application remains challenged by variability in efficacy, timing of administration, and patient-specific factors
Careful record-keeping is essential for successful claims processing
Rather than viewing injectable glutathione as an isolated intervention, progressive healthcare providers incorporate it within holistic strategies that address the multifactorial nature of aging and health optimization